Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears In-Line's access blood flow monitor:

This article was originally published in Clinica

Executive Summary

In-Line Diagnostics has received US FDA 510(k) clearance to market its device for estimating access blood flow rate. The Transcutaneous Access Flow consists of a sensor that uses photo-optical technology to acquire a reading in a matter of minutes, compared to 15-20 minutes with current techniques, claims the Salt Lake City, Utah-based company. The device is for use with In-Line's Crit-Line blood monitoring system.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069498

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel